PMP2-Related Charcot-Marie-Tooth Disease Type 1 ( CMT1 / CMT1G)

PMP2-related Charcot-Marie-Tooth disease type 1 (often called PMP2-related CMT1 or CMT1G) is a very rare inherited nerve disease. It happens when the PMP2 gene, which makes a small protein in the myelin (the “insulation” around peripheral nerves), has a harmful change (mutation). This weak myelin makes nerve signals travel more slowly and less strongly to the feet, legs, hands, and arms. Over time, people can develop foot deformities (high arches, claw toes), weakness, balance problems, and sensory loss.ScienceDirect+4Orpha+4PMC+4

PMP2-related Charcot-Marie-Tooth disease type 1 is a very rare inherited nerve disease that mainly affects the long nerves to the feet, legs, hands, and arms. It happens when there is a harmful change (mutation) in a gene called PMP2. This gene gives the body instructions to make a small protein called peripheral myelin protein 2, which is part of the myelin sheath (the “insulation coat”) around peripheral nerves. When this protein is changed, the myelin becomes weak and damaged, so nerve signals travel more slowly. Orpha+1

PMP2-related CMT1 behaves like other demyelinating CMT type 1 forms: symptoms usually begin in childhood or teenage years, progress slowly, and often affect the lower limbs first. There is no cure yet, and no drug is approved specifically to “fix” the gene or fully stop the disease. Treatment focuses on rehabilitation, pain control, braces, and surgery for severe deformities, while researchers are testing gene therapy and other regenerative options in clinical trials for CMT in general.PMC+4PMC+4Charcot-Marie-Tooth Association+4

Doctors group this disease inside Charcot-Marie-Tooth disease type 1 (CMT1). CMT1 is a family of demyelinating neuropathies, meaning the main problem is damage to myelin rather than the nerve core (axon). People usually develop slowly progressive weakness and wasting of muscles in the feet and lower legs, less feeling in the feet, and often high-arched feet or other foot problems. Orpha+1

The specific subtype linked to PMP2 is often called CMT1G. It is usually autosomal dominant, which means a person needs only one copy of the changed gene from one parent to have the condition. Symptoms usually start in childhood or the teenage years and get slowly worse over many years. MalaCards+2UniProt+2

In research families, nerve tests show slow nerve conduction, which fits with a demyelinating neuropathy, and nerve biopsies show loss of myelin and “onion bulb” formations (layers of abnormal myelin around nerves). These changes match what doctors see in other types of CMT1. PMC+2PMC+2

This explanation is for learning only. It cannot replace advice from your own doctor or neurologist. If you or someone you know has symptoms like those described, please see a health professional. NCBI+1

---

Other names

Doctors and researchers use several other names for PMP2-related Charcot-Marie-Tooth disease type 1. These names all describe the same or very closely related condition:

• PMP2-related CMT1 – This name means Charcot-Marie-Tooth type 1 caused by a mutation in the PMP2 gene. Global Genes+1

• PMP2-related Charcot-Marie-Tooth neuropathy type 1 – “Neuropathy” means a disease of the nerves. This name makes it clear that both motor (movement) and sensory (feeling) nerves are involved. Global Genes+1

• PMP2-related hereditary motor and sensory neuropathy type 1 – “Hereditary” means it runs in families. “Motor and sensory” means both movement and feeling are affected. “Type 1” shows it is a demyelinating form. Global Genes+1

• Charcot-Marie-Tooth disease, demyelinating, type 1G (CMT1G) – This is the formal genetic name. “1G” is the code for the subtype linked to PMP2. MalaCards+1

---

Types (clinical patterns)

Doctors do not have official “sub-subtypes” inside PMP2-related CMT1, but patients can be grouped by how and when the disease shows itself. These groups help doctors explain the condition, even though they are not separate genetic types. MDPI+1

• Typical childhood-onset type
  In this pattern, symptoms begin in late childhood or early teenage years. Children may start to trip more, run more slowly, or show early foot deformities. Nerve tests show clear demyelination, and problems progress slowly over life. PMC+2PLOS+2

• Adolescent-onset type with milder course
  Some people first notice problems in later teenage years or young adulthood. Weakness and numbness may stay mild for a long time. They may have subtle foot changes and only slight trouble with running or sports. MDPI+2CMT Research Foundation+2

• Early-childhood more severe type
  In a few families, children show symptoms quite early, such as delayed walking, frequent falling, and very high arches or hammertoes. Their nerve conduction can be very slow, and disability may appear earlier. MDPI+2Wiley Online Library+2

• Adult-recognized type
  Sometimes the disease has been present since youth, but it is only recognized in adulthood, when foot problems, balance issues, or hand weakness become obvious. In these cases the course is usually slowly progressive but compatible with long life. NCBI+2Mayo Clinic+2

---

Causes and risk factors

Important: In a strict medical sense, the true cause of PMP2-related CMT1 is the PMP2 gene mutation. Other things below mainly worsen nerve damage or symptoms in someone who already has the mutation.

1. Pathogenic PMP2 gene mutation
   The main cause is a harmful change in the PMP2 gene. This mutation changes the structure of peripheral myelin protein 2, so it cannot bind and handle lipids in myelin correctly. This leads to weak myelin and slow nerve signals. PMC+2PLOS+2

2. Autosomal dominant inheritance from a parent
   Many patients inherit the mutated PMP2 gene from an affected parent. Because the condition is autosomal dominant, just one copy of the bad gene is enough to cause disease. Each child of an affected person has a 50% chance to inherit it. Orpha+2MalaCards+2

3. De novo (new) PMP2 mutation
   In some families, the mutation is new in the child and is not found in either parent. This is called a de novo mutation. The child can then pass this new mutation on to their own children. PMC+2scholarship.miami.edu+2

4. Gain-of-function effect of PMP2 protein
   Some PMP2 mutations seem to make the protein overly active or abnormal in how it binds lipids. This “gain-of-function” effect can disturb normal myelin structure and stability, causing demyelination. PLOS+2ResearchGate+2

5. Schwann cell dysfunction
   Schwann cells are the cells that make myelin in peripheral nerves. Faulty PMP2 inside Schwann cells interferes with their ability to build and maintain healthy myelin, leading to slowly progressive nerve damage. CMT Research Foundation+2Neurology Asia+2

6. Segmental demyelination of motor fibers
   Motor nerve fibers to the leg and foot muscles lose myelin in short segments. This demyelination slows signals and causes weakness and muscle wasting, especially in the peroneal muscles around the shin and ankle. MalaCards+2Genomics Education Programme+2

7. Segmental demyelination of sensory fibers
   Sensory fibers that carry touch, pain, and vibration signals from the feet also lose myelin. This leads to numbness, reduced feeling, and problems with balance because the brain gets weaker messages from the feet. MalaCards+2NCBI+2

8. Onion bulb formation and chronic myelin repair
   In long-lasting disease, Schwann cells try to repair myelin again and again. This repeated wrapping of thin myelin can form “onion bulbs” seen on nerve biopsy. These changes show chronic demyelination and remyelination. Neurology Asia+2PMC+2

9. Modifier genes in the background
   Other genes in a person’s DNA may influence how strongly the PMP2 mutation shows its effect. Some people with the same mutation have milder or more severe signs, likely due to these extra genetic factors. MDPI+2CMT Research Foundation+2

10. Nerve length dependence
    Longer nerves are more vulnerable to demyelination. Because the nerves to the feet and legs are longest, they show symptoms first, which is why people notice problems in their lower limbs before their hands. NCBI+2Orpha+2

11. Diabetes (worsening factor)
    Diabetes can cause its own neuropathy. If someone with a PMP2 mutation also develops diabetes, the two problems can add together, causing more severe nerve damage, more numbness, and faster decline. NCBI+2Mayo Clinic+2

12. Alcohol overuse (worsening factor)
    Long-term heavy alcohol use is toxic to peripheral nerves. In a person with PMP2-related CMT1, alcohol can further injure nerves and speed up weakness and numbness. NCBI+2Wikipedia+2

13. Certain chemotherapy drugs (worsening factor)
    Some chemotherapy medicines, such as vincristine and paclitaxel, can damage peripheral nerves. In people with hereditary neuropathies like CMT, these medicines may trigger sudden worsening of symptoms. Mayo Clinic+2NCBI+2

14. Nutritional deficiencies (worsening factor)
    Lack of vitamin B12, vitamin B6, or other nutrients important for nerve health can make neuropathy worse. In someone with PMP2-related disease, poor nutrition may increase fatigue, numbness, and balance problems. NCBI+2Neurology Asia+2

15. Mechanical compression of nerves
    Tight shoes, repeated ankle sprains, or frequent pressure on nerves (for example at the fibular head near the knee) can further injure already fragile nerves, causing more weakness or temporary palsies. Orpha+2Genomics Education Programme+2

16. Obesity and reduced physical activity
    Extra body weight and low activity can reduce muscle strength and worsen balance. In PMP2-related CMT1, this can increase fatigue, falls, and joint strain, although it does not cause the genetic disease itself. NCBI+1

17. Smoking and poor circulation
    Smoking damages small blood vessels that feed nerves. Poor blood supply can make neuropathic symptoms worse and slow recovery from minor injuries. NCBI+2Wikipedia+2

18. Infections and general illnesses
    Severe infections or illness can temporarily lower strength and function in people with CMT. They may notice more weakness or numbness during and shortly after being ill, even though the underlying mutation is unchanged. NCBI+1

19. Repetitive overuse of weak muscles
    Overworking muscles that are already weak and denervated may increase fatigue and pain. Careful, guided physiotherapy is safer than intense, unsupervised exercise. NCBI+2Mayo Clinic+2

20. Lack of supportive shoes and orthotics
    Without good footwear or braces, foot deformities and instability can lead to more falls, sprains, and joint damage. These mechanical problems do not cause the gene mutation but increase disability from it. NCBI+2Global Genes+2

---

Symptoms

In PMP2-related CMT1, symptoms usually start in the feet and lower legs and progress slowly over many years. The pattern is similar to other forms of CMT1, but caused by PMP2 mutations. Orpha+2MalaCards+2

1. Weakness in feet and ankles
   People often notice they cannot lift the front of the foot well. This is called “foot drop”. It makes it hard to walk fast, climb stairs, or run. NCBI+2Mayo Clinic+2

2. Frequent tripping and falls
   Because the foot cannot lift properly, it may drag on the ground. This leads to catching the toes on small objects, stumbling, and falling more often than expected for age. NCBI+2Mayo Clinic+2

3. Muscle wasting in lower legs
   Over time the muscles below the knee shrink, especially at the front and sides of the shin. The lower legs can look thin, sometimes described as an “inverted champagne bottle” shape. NCBI+2MalaCards+2

4. High-arched feet (pes cavus)
   Many patients develop high arches and other foot deformities, such as hammertoes. These changes come from long-term muscle imbalance between weak and stronger muscles in the foot. Orpha+2NCBI+2

5. Hammertoes and clawing of toes
   Toes may bend abnormally at the joints because some muscles overpull while others are weak. This can cause pain, calluses, and trouble finding comfortable shoes. NCBI+2Mayo Clinic+2

6. Numbness in feet and toes
   People often feel reduced touch, temperature, or pain in their feet. They may not notice small injuries or blisters, which can then become infected if not seen and treated. NCBI+2Mayo Clinic+2

7. Pins-and-needles or tingling sensations
   Some patients feel burning, tingling, or “electric” sensations in their feet or hands. These abnormal feelings (paresthesias) come from damaged sensory fibers. NCBI+2Wikipedia+2

8. Loss of vibration and position sense
   People may have difficulty feeling vibration from a tuning fork or knowing exactly where their feet are without looking. This can lead to unsteady walking, especially in the dark. NCBI+2Genomics Education Programme+2

9. Reduced or absent reflexes
   When doctors test reflexes at the ankle or knee, responses may be weak or absent. This is a typical feature of demyelinating neuropathies like CMT1G. MalaCards+2Orpha+2

10. Weakness in hands and fingers
    As the disease progresses, it can involve nerves to the hands. People may have trouble with fine tasks like buttoning, writing, or opening jars. MalaCards+2NCBI+2

11. Hand muscle wasting
    The small muscles of the hands can shrink, making the spaces between the bones more visible. Grip strength may drop, and hand fatigue is common. MalaCards+2NCBI+2

12. Balance problems and unsteady gait
    Because of weakness and poor sensation, walking can become unsteady. People may widen their stance, look down at their feet more, or avoid walking on uneven ground. NCBI+2Mayo Clinic+2

13. Fatigue and reduced stamina
    Walking and standing require more effort when muscles and nerves are weak. People often feel tired more quickly and may limit activities to manage fatigue. NCBI+2Mayo Clinic+2

14. Muscle cramps or spasms
    Some patients report cramps in the calf or foot muscles, especially in the evening or after activity. These cramps come from unstable nerve signals to muscles. NCBI+2MalaCards+2

15. Mild neuropathic pain
    While many patients mainly have sensory loss, some have burning or aching pain in their feet or legs. This pain is usually chronic and mild to moderate but can still affect sleep and mood. NCBI+2Mayo Clinic+2

---

Diagnostic tests

Doctors diagnose PMP2-related CMT1 by combining the story of symptoms, physical examination, nerve tests, and genetic testing. They also check for other causes of neuropathy so they do not miss a different or additional disease. NCBI+2Orpha+2

Physical exam tests

1. General neurological examination
   The neurologist checks strength, sensation, reflexes, coordination, and cranial nerves. In PMP2-related CMT1, they often find distal (far-from-the-body) weakness, sensory loss in the feet, and reduced reflexes. NCBI+2Orpha+2

2. Gait observation and walking assessment
   The doctor watches how the person walks. They look for foot drop, high-stepping gait, ankle instability, and frequent tripping. This simple test shows how neuropathy affects daily movement. NCBI+2Mayo Clinic+2

3. Foot and leg inspection
   The examiner looks for high arches, hammertoes, inverted heel, calluses, and muscle wasting in the calves. These visible signs are classic clues for CMT1-type neuropathies. Orpha+2NCBI+2

4. Deep tendon reflex testing
   Using a reflex hammer, the doctor taps the Achilles, knee, and other tendons. In demyelinating CMT, these reflexes are often weak or absent, especially at the ankles. MalaCards+2Genomics Education Programme+2

Manual tests

5. Manual muscle testing of distal muscles
   The examiner asks the patient to push or pull against resistance at the ankles, toes, wrists, and fingers. They grade strength on a standard scale, which helps track disease progression over time. NCBI+2Genomics Education Programme+2

6. Light touch and pinprick sensory testing
   Using cotton, a small piece of tissue, or a disposable pin, the doctor checks how well the patient feels touch and pain. Reduced feeling in a “stocking-glove” pattern supports a length-dependent neuropathy like CMT. NCBI+2Neurology Asia+2

7. Vibration sense with tuning fork
   A vibrating tuning fork is placed on the big toe or ankle. Many patients with CMT1 have reduced vibration sense, which reflects large-fiber sensory nerve involvement. NCBI+2Genomics Education Programme+2

8. Romberg balance test
   The patient stands with feet together, first with eyes open and then with eyes closed. Swaying or falling when eyes are closed shows that the body is relying heavily on vision because joint position sense is poor. NCBI+2Genomics Education Programme+2

9. Heel-toe and tandem walking tests
   Walking on heels, toes, or a straight line (tandem gait) can reveal subtle balance and strength problems. People with PMP2-related CMT1 may find these tasks difficult, especially on heels. NCBI+2Mayo Clinic+2

Lab and pathological tests

10. Basic blood tests to exclude other neuropathies
    Doctors often order tests such as blood sugar, kidney and liver function, thyroid hormones, vitamin B12, and sometimes autoimmune markers. Normal results support a hereditary cause like CMT rather than an acquired neuropathy. NCBI+2Neurology Asia+2

11. Genetic panel for Charcot-Marie-Tooth disease
    Many labs offer multi-gene panels that test common CMT genes, including PMP22, MPZ, and PMP2. Finding a known PMP2 mutation confirms the diagnosis of PMP2-related CMT1. CMT Research Foundation+2Genomics Education Programme+2

12. Targeted PMP2 gene sequencing
    If a CMT panel suggests or if there is a strong family pattern, doctors may order specific sequencing of the PMP2 gene. This can detect rare or new PMP2 variants in affected families. PMC+2PMC+2

13. Whole-exome or whole-genome sequencing
    In complex or unclear cases, broader sequencing can be used. Exome studies have been key tools in discovering PMP2 mutations in families with unexplained demyelinating CMT. PMC+2PMC+2

14. Sural nerve biopsy
    In some cases, especially before genetic testing was widely available, doctors took a small nerve sample from the leg (sural nerve). In PMP2-related CMT1 they see fewer myelinated fibers, myelin abnormalities, and onion bulb formations. Orpha+2Neurology Asia+2

15. Pathology with electron microscopy and special stains
    Under high magnification, nerve biopsies show details of myelin damage and Schwann cell changes. These findings confirm a chronic demyelinating neuropathy pattern, consistent with CMT1. Neurology Asia+2PMC+2

Electrodiagnostic tests

16. Motor nerve conduction studies (NCS)
    NCS measure how fast and how strongly electrical signals travel along motor nerves. In demyelinating CMT1, conduction velocities are usually less than about 38 m/s, with slow responses but relatively preserved axons early on. MalaCards+2Neurology Asia+2

17. Sensory nerve conduction studies
    Similar tests on sensory nerves show reduced or absent sensory responses, especially in the feet. These results match the patient’s numbness and help distinguish hereditary neuropathies from other conditions. NCBI+2Neurology Asia+2

18. Needle electromyography (EMG)
    EMG assesses the electrical activity inside muscles. In chronic neuropathy, it may show signs of denervation and re-innervation, such as large motor units. EMG helps rule out primary muscle diseases. NCBI+2Neurology Asia+2

Imaging tests

19. Foot and ankle X-rays
    X-rays can show high arches, hammertoes, and joint changes caused by long-term muscle imbalance. They help surgeons plan orthopaedic treatment if needed. NCBI+2Mayo Clinic+2

20. MRI or ultrasound of peripheral nerves and muscles
    MRI or nerve ultrasound can show fatty replacement of calf muscles and sometimes thickened nerves in hereditary neuropathies. While not specific for PMP2, these images support the diagnosis of a long-standing peripheral neuropathy. Monarch Initiative+2Neurology Asia+2

---

Non Pharmacological Treatments

1. Physical therapy (PT)
Physical therapy is one of the main treatments for PMP2-related CMT1. Purpose: keep muscles strong and flexible, improve balance, and slow joint stiffness. How it works: a physiotherapist designs safe exercises for ankles, knees, hips, and core, including stretching, gentle strengthening, and balance training. Regular PT can reduce falls, delay contractures, and help you stay independent in walking and daily life.nhs.uk+2Muscular Dystrophy Association+2

2. Occupational therapy (OT)
Occupational therapy focuses on hands, arms, and daily activities such as dressing, writing, typing, cooking, or using a phone. Purpose: make everyday tasks easier and safer. How it works: the therapist teaches joint-protecting techniques, recommends adaptive tools (special pens, grips, button hooks), and shows energy-saving ways to do chores. OT helps you stay active at school, work, and home even with weakness and numbness.nhs.uk+1

3. Ankle-foot orthoses (AFOs) and leg braces
AFOs are lightweight plastic or carbon braces worn in the shoes to hold the ankle in a good position. Purpose: reduce foot drop, prevent ankle sprains, and improve walking. How it works: by keeping the ankle at 90 degrees and stabilizing the heel, AFOs make each step more stable and reduce tripping, especially when leg muscles are weak. Many CMT guidelines recommend early orthotic use to prevent falls and deformities.Mayo Clinic+2Charcot-Marie-Tooth Association+2

4. Custom shoes and foot orthotics
People with CMT often have high arches and claw toes that make standard shoes painful. Purpose: protect the feet, spread pressure evenly, and improve stability. How it works: custom insoles, rocker-bottom soles, and wide, deep shoes give space for deformities and braces and reduce pressure points that can cause calluses and ulcers. Proper footwear can delay or even prevent the need for surgery.medschool.cuanschutz.edu+1

5. Stretching and contracture prevention
Tight calf muscles and Achilles tendons are very common in CMT and make the foot point down (equinus). Purpose: keep joints moving and avoid fixed deformities. How it works: daily gentle stretches of calves, hamstrings, and feet, taught by a therapist, hold muscles at a comfortable length. Over time this reduces pain, improves stride, and lowers the chance that you will need tendon-lengthening surgery.www.elsevier.com+1

6. Strength training with low resistance
Weakness in the ankles and knees makes walking harder. Purpose: improve strength without over-fatiguing fragile nerves and muscles. How it works: therapists use light resistance bands and body-weight exercises, focusing on small, controlled movements and many rest breaks. CMT experts recommend avoiding heavy weights or high-impact sports but support carefully supervised strengthening to maintain function.nhs.uk+2Charcot-Marie-Tooth Disease+2

7. Low-impact aerobic exercise (walking, cycling, swimming)
Long-term nerve disease can reduce fitness and increase fatigue. Purpose: boost heart and lung health, mood, and stamina. How it works: low-impact activities such as walking on flat ground, stationary cycling, or swimming put less pressure on weak ankles and arches. Short, regular sessions (for example 20–30 minutes most days) are safer than intense bursts.nhs.uk+2Charcot-Marie-Tooth Disease+2

8. Balance and fall-prevention training
Numbness in the feet makes it hard to feel the ground. Purpose: reduce falls and fear of falling. How it works: therapists use simple exercises such as standing on a firm surface with feet together, stepping over obstacles, or walking along a tape line, sometimes using balance boards or foam. They also teach how to turn safely and how to get up if you do fall.Muscular Dystrophy Association+1

9. Hand therapy, splints, and fine-motor training
Hand weakness and tremor can make writing, using cutlery, or buttoning clothes difficult. Purpose: protect joints and improve hand function. How it works: exercises target finger strength and coordination; wrist or thumb splints can stabilize joints, while special tools (built-up handles, easy-grip scissors) make tasks easier and less tiring.Hand Surgery Resource+1

10. Assistive devices (canes, walkers, wheelchairs)
Some people eventually need a cane, walker, or wheelchair for longer distances. Purpose: improve safety and independence, not to “give up.” How it works: a properly sized cane or walker widens your base of support and reduces the load on weak ankles. A wheelchair or scooter for long trips can conserve energy for school, work, or social life.PMC+1

11. Home safety changes
Clutter, loose rugs, and poor lighting increase fall risk in neuropathy. Purpose: create a safer home and bathroom. How it works: simple changes such as grab bars, non-slip mats, nightlights, and removing trip hazards greatly reduce accidents. An occupational therapist can visit the home and give personalized suggestions.Muscular Dystrophy Association+1

12. Pain psychology and cognitive-behavioural therapy (CBT)
Chronic neuropathic pain affects mood, sleep, and school/work performance. Purpose: help people cope with pain and reduce suffering. How it works: CBT teaches skills like relaxation, goal-setting, activity pacing, and changing unhelpful thoughts. Studies in chronic pain show CBT can reduce pain intensity and disability, even when the nerve damage itself does not change.Charcot-Marie-Tooth Association+1

13. Sleep hygiene and fatigue management
Pain, muscle cramps, and anxiety often disturb sleep. Purpose: improve sleep quality and daily energy. How it works: keeping regular bedtimes, limiting caffeine, using comfortable braces at night if advised, and practising relaxation before bed can help. Planned rest breaks during the day prevent over-tiredness and “crashes.”Charcot-Marie-Tooth Association+1

14. Nutritional counselling and weight management
Extra body weight puts more stress on weak feet, ankles, and knees. Purpose: keep a healthy weight and support nerve health. How it works: a dietitian can design a balanced diet rich in whole grains, fruit, vegetables, lean protein, and healthy fats, while limiting sugary drinks and ultra-processed food. This helps joint health, energy, and possibly nerve function.Frontiers+1

15. Foot care and podiatry
Because sensation is reduced, small foot injuries can be missed. Purpose: prevent ulcers, infections, and serious deformities. How it works: regular checks by a podiatrist, proper nail trimming, callus care, and early treatment of blisters or sores reduce complications. Daily self-inspection of the feet is strongly encouraged in neuropathy.medschool.cuanschutz.edu+1

16. Genetic counselling for patients and family
PMP2-related CMT1 is inherited, usually in an autosomal dominant pattern, meaning one changed copy of the gene can cause disease. Purpose: help families understand inheritance, testing, and pregnancy options. How it works: a genetic counsellor explains risks to children and relatives, offers testing where appropriate, and supports emotional decision-making.Orpha+2PMC+2

17. Psychological support and peer groups
Living with a chronic rare disease can feel lonely. Purpose: emotional support and practical advice. How it works: meeting other people with CMT in support groups (online or in person) and seeing a psychologist if needed can reduce anxiety, depression, and isolation. Patient organizations also share research updates and practical tips.Charcot-Marie-Tooth Association+1

18. School and workplace accommodations
Fatigue, reduced hand strength, and walking difficulty can affect study or work. Purpose: allow you to perform at your best with fair support. How it works: examples include extra time for exams, permission to use a laptop, closer parking, flexible working hours, or remote work options. Many disability laws support reasonable accommodations.Charcot-Marie-Tooth Association+1

19. Regular neurologist and multidisciplinary follow-up
Because CMT changes slowly over years, regular check-ups are important. Purpose: track progression, adjust braces and therapy, and manage new problems early. How it works: neurologists, physiatrists, orthopedic surgeons, therapists, and podiatrists work together in a “CMT clinic” model to give coordinated care.Muscular Dystrophy Association+2PMC+2

20. Early orthopedic consultation
When foot deformities become rigid, non-surgical treatments may not be enough. Purpose: decide the best moment for surgery, if needed, before joints are badly fixed. How it works: orthopedic foot and ankle specialists assess your gait, X-rays, and brace response, and plan tendon transfers or bone corrections when conservative measures fail.medschool.cuanschutz.edu+3PMC+3PMC+3

---

Drug Treatments

There is no drug currently approved specifically for PMP2-related CMT1. Medicines are used to treat neuropathic pain, muscle spasms, and other symptoms. Below are 10 key drugs commonly used in inherited neuropathies and related conditions, with information mainly from U.S. FDA labels on accessdata.fda.gov. All dosing must be individualized by a doctor.PMC+1

1. Gabapentin
Gabapentin is an anti-seizure drug widely used for neuropathic pain, such as postherpetic neuralgia. Class: calcium-channel modulator (α2δ subunit). Typical adult dosing for neuropathic pain starts at about 300 mg once daily and is slowly increased, often to 900–1800 mg/day in divided doses, depending on kidney function. Purpose: reduce burning, stabbing, or tingling pain. Mechanism: it reduces excitability of pain-carrying nerves. Common side effects include dizziness, sleepiness, and swelling in legs.FDA Access Data+3FDA Access Data+3FDA Access Data+3

2. Pregabalin
Pregabalin is similar to gabapentin and is FDA-approved for neuropathic pain in diabetic neuropathy, postherpetic neuralgia, spinal cord injury, and for fibromyalgia and seizures. Class: α2δ calcium-channel modulator. Usual adult doses for neuropathic pain are 150–300 mg/day divided into two or three doses (for example 75 mg twice daily), adjusted for kidney function. Purpose: decrease neuropathic pain and improve sleep. Side effects can include dizziness, fluid retention, weight gain, and blurred vision.FDA Access Data+3FDA Access Data+3FDA Access Data+3

3. Duloxetine
Duloxetine is an antidepressant in the SNRI class and is FDA-approved for diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain, depression, and anxiety. Class: serotonin-norepinephrine reuptake inhibitor. A common adult dose for neuropathic pain is 60 mg once daily. Purpose: reduce chronic nerve pain and improve mood and sleep. Mechanism: increasing serotonin and norepinephrine in pain pathways. Side effects may include nausea, dry mouth, sleepiness, increased sweating, and blood pressure changes.FDA Access Data+3FDA Access Data+3FDA Access Data+3

4. Amitriptyline
Amitriptyline is an older tricyclic antidepressant often used off-label for neuropathic pain and migraine prevention. Class: tricyclic antidepressant. Dosing for pain typically starts very low (10–25 mg at night) and may be slowly increased, but higher doses are limited by side effects. Purpose: improve pain and sleep. Mechanism: blocks reuptake of serotonin and norepinephrine and modulates pain signalling. Common side effects are dry mouth, constipation, weight gain, and drowsiness; it should be used carefully in heart disease and is not first choice in teens.FDA Access Data+1

5. Tramadol
Tramadol is an opioid-like pain medicine used for moderate to moderately severe pain. Class: weak μ-opioid agonist plus SNRI-like activity. Typical adult doses for immediate-release tablets are around 50–100 mg every 4–6 hours as needed, with a maximum daily dose specified in the label depending on the product. Purpose: treat pain that does not respond to milder medicines. Side effects include nausea, dizziness, constipation, sleepiness, and serious risks such as addiction, breathing problems, and seizures, especially at higher doses or with other medicines.FDA Access Data+4FDA Access Data+4FDA Access Data+4

6. Baclofen (oral or intrathecal)
Baclofen is a muscle relaxant used for spasticity and sometimes for painful muscle cramps. Class: GABA-B receptor agonist. Oral adult doses usually start low (for example 5 mg three times daily) and are slowly increased; intrathecal baclofen pumps are reserved for severe spasticity. Purpose: reduce muscle stiffness and cramping that may add to discomfort and limit mobility. Side effects can include drowsiness, weakness, dizziness, and withdrawal reactions if stopped suddenly.FDA Access Data+3FDA Access Data+3FDA Access Data+3

7. Naproxen
Naproxen is a non-steroidal anti-inflammatory drug (NSAID) used for musculoskeletal pain, joint pain, and cramps. Class: NSAID. Over-the-counter naproxen sodium for adults is usually 220 mg every 8–12 hours, with label-specified maximum doses; prescription forms allow higher doses. Purpose: reduce pain from muscle strain, joint stress, or post-surgical pain rather than true neuropathic pain. Side effects include stomach irritation, bleeding risk, kidney strain, and increased cardiovascular risk at higher doses or long-term use.FDA Access Data+3FDA Access Data+3FDA Access Data+3

8. Ibuprofen
Ibuprofen is another NSAID for mild to moderate pain and fever. Class: NSAID. Typical adult over-the-counter doses are 200–400 mg every 4–6 hours, with strict limits on total daily dose. Purpose: treat headaches, minor muscle or joint pain, and post-exercise soreness that may accompany CMT but is not due to nerve damage itself. Side effects are similar to naproxen: stomach upset, bleeding risk, kidney effects, and rare allergic reactions.FDA Access Data+3FDA Access Data+3FDA Access Data+3

9. Topical lidocaine 5% patch
Lidocaine 5% patches are placed on the skin over areas of localized neuropathic pain (for example postherpetic neuralgia). Class: local anaesthetic. The FDA label usually recommends up to 3 patches at one time for up to 12 hours within a 24-hour period, on intact skin only. Purpose: numb painful skin regions with low systemic side effects. Common side effects are local skin irritation or redness; serious systemic toxicity is rare if used correctly.FDA Access Data+3FDA Access Data+3FDA Access Data+3

10. Capsaicin 8% patch (Qutenza)
Capsaicin 8% patches are used in clinic to treat certain neuropathic pains such as postherpetic neuralgia. Class: topical TRPV1 receptor agonist. The patch is applied by a trained professional for about 60 minutes to the painful area, and treatment can be repeated after several months if needed. Purpose: “defunctionalize” pain-carrying nerve endings and reduce pain for weeks to months. Side effects include burning, redness, and temporary increased pain at the site right after application.FDA Access Data+3FDA Access Data+3FDA Access Data+3

Because PMP2-related CMT1 is rare and usually begins in childhood, drug choices and doses must be handled by neurologists and paediatric specialists. Many of these medicines are not first-line in children or teens.

---

Dietary Molecular Supplements

None of these supplements is proven to cure CMT, but some have been studied in diabetic or other peripheral neuropathies. Always ask your doctor before starting them, because they can interact with medicines or be unsafe at high doses.

1. Alpha-lipoic acid (ALA)
ALA is an antioxidant used in several trials for diabetic peripheral neuropathy. Typical study doses are about 600 mg once or twice daily for a few weeks. Purpose: reduce oxidative stress in nerves and improve pain and nerve blood flow. Some studies show symptom improvement, but long-term benefits and safety are still being studied, and results are mixed.neurology.org+3PubMed+3ClinicalTrials.gov+3

2. Acetyl-L-carnitine (ALC)
ALC is involved in energy production in nerve cells and mitochondria. Trials in painful peripheral neuropathy have used doses around 1000–3000 mg/day, divided. Purpose: support nerve energy metabolism and reduce pain. Some meta-analyses suggest moderate pain improvement and possible nerve regeneration, but other trials show uncertain or even negative effects in chemotherapy-induced neuropathy, so careful medical supervision is needed.ScienceDirect+4PubMed+4PLOS+4

3. Omega-3 fatty acids (EPA/DHA)
Omega-3 polyunsaturated fatty acids from fish oil or algae may support nerve repair and reduce inflammation. Study doses vary (often 1–3 g/day of combined EPA and DHA). Purpose: protect nerve cell membranes and support regeneration after injury. Animal and human data suggest improved nerve function and reduced neuropathy in some settings, but specific evidence in CMT is still limited.Wiley Online Library+4PMC+4Frontiers+4

4. Vitamin B12 (cyanocobalamin or methylcobalamin)
Vitamin B12 is essential for myelin and nerve health. In people with B12 deficiency neuropathy, doses can be high (for example 1000 µg injections or high-dose oral tablets), but exact dosing must be individualized. Purpose: correct deficiency to avoid additional nerve damage. B12 does not fix genetic CMT but is important to avoid “double” nerve problems from deficiency.MDPI+4NCBI+4Cleveland Clinic+4

5. Vitamin D
Vitamin D helps bone health, muscle strength, and immune balance. Doses depend on blood levels, often 800–2000 IU/day in deficiency, but testing and guidance by a doctor are essential. Purpose: maintain bone strength, reduce fracture risk, and support general health in people with weak muscles and frequent falls. Evidence for direct nerve repair is limited but deficiency is common.MDPI

6. Magnesium
Magnesium is important for muscle and nerve function. Supplement doses vary (for example 200–400 mg/day in adults) and must be adapted in kidney disease. Purpose: help muscle cramps and support normal nerve signalling. Data in CMT are lacking, but magnesium is sometimes used in general neuropathy or cramp management.MDPI

7. Curcumin (from turmeric)
Curcumin has anti-inflammatory and antioxidant properties. Common supplement doses range from about 500–1000 mg/day in studies of joint pain or metabolic disease. Purpose: reduce chronic inflammation that might worsen pain. Evidence for peripheral neuropathy is early and mostly experimental, so curcumin should be seen as supportive, not disease-modifying.MDPI+1

8. Resveratrol
Resveratrol is a plant polyphenol studied for antioxidant and mitochondrial effects. Doses in studies vary widely (for example 150–500 mg/day). Purpose: support cellular energy and reduce oxidative damage. Data in neuropathy are limited and still experimental; it should not replace standard therapy.MDPI+1

9. Coenzyme Q10 (CoQ10)
CoQ10 is part of the mitochondrial electron transport chain and has been used in some neuromuscular disorders. Typical supplement doses are 100–300 mg/day. Purpose: support muscle and nerve energy production and possibly reduce fatigue. Evidence in CMT is sparse; benefits are most clear when there is a proven mitochondrial deficiency.PLOS+1

10. Balanced multivitamin with B-complex
A standard multivitamin that includes B1 (thiamine), B6, and B12 can help cover basic nutritional needs, but high-dose B6 can itself cause neuropathy, so doses must stay within recommended limits. Purpose: avoid vitamin deficiency that can worsen nerve problems. Mechanism: provide cofactors needed for nerve repair and myelin maintenance.NCBI+2ScienceDirect+2

---

Regenerative and Stem Cell–Related Drugs and Approaches

At present, there are no approved stem cell or gene therapies for PMP2-related CMT1. Below are areas of research and “regenerative” strategies being studied mainly in CMT1A and other CMT types; they may become relevant for PMP2-related CMT1 in the future.

1. High-dose ascorbic acid (Vitamin C) trials
High-dose vitamin C was tested in several CMT1A trials because it improved neuropathy in mouse models. Human trials using 1.5–4 g/day for long periods did not show clear benefit, and it is not recommended as a standard treatment, but research taught important lessons about trial design in CMT.CenterWatch+5PubMed+5ClinicalTrials.gov+5

2. PXT3003 (baclofen, naltrexone, D-sorbitol combination)
PXT3003 is an experimental oral combination drug studied in phase II and III trials for CMT1A. The idea is that each component lowers PMP22 over-expression and improves myelin health. Early trials suggested potential benefit; large phase III studies (like PREMIER) are ongoing. It is not yet approved and not specific for PMP2 mutations, but it illustrates how combination drugs may target myelin biology.umiamihealth.org+6ClinicalTrials.gov+6ClinicalTrials.gov+6

3. Neurotrophin-3 (NT-3) protein and gene therapy
Neurotrophin-3 is a growth factor that supports Schwann cells and nerve regeneration. Pilot trials in CMT1A and animal studies showed that NT-3 can improve nerve conduction and regeneration, but regular protein injections were limited by short half-life. Gene therapy using AAV1 vectors to deliver NT-3 to muscle (which then releases it to nerves) is now being tested in small human trials.AFM Téléthon+5PubMed+5ClinicalTrials.gov+5

4. Broader gene therapy strategies for CMT
Gene therapy approaches aim to correct or silence faulty genes in CMT. For various subtypes, researchers are exploring AAV-based vectors, plasmid-based therapies, and gene replacement or silencing technologies. These methods have worked in animal models and early trials in other genetic diseases (such as spinal muscular atrophy). Clinical trials for some CMT subtypes are in early phases, showing promise but still needing safety and long-term follow-up.AFM Téléthon+4CMT Research Foundation+4institut-myologie.org+4

5. Stem cell–based approaches (experimental)
Researchers are studying mesenchymal stem cells and other cell types as potential treatments for peripheral neuropathy. The idea is that stem cells might release growth factors that support myelin repair and axon regeneration. So far, this work is mostly in animal models or early-phase trials; there is no evidence-based, approved stem cell therapy for CMT yet, and such treatments should only be tried within regulated clinical trials.PMC+2Frontiers+2

6. Optimized nutrition and exercise as “natural regenerative support”
Good nutrition (enough protein, vitamins, and omega-3 fats) plus tailored exercise may not directly “regrow” nerves but can create a better environment for the body’s own repair mechanisms. Studies in other neuropathies show that omega-3 fatty acids and structured rehabilitation can help nerve recovery after injury, which is why similar strategies are recommended in inherited neuropathies as supportive care.PMC+5PMC+5Frontiers+5

---

Surgeries (Main Procedures and Why They Are Done)

Surgery in PMP2-related CMT1 does not fix the nerve disease. It corrects deformities to improve walking, comfort, and shoe wear when braces and therapy are no longer enough.

1. Tendon transfer surgery
In CMT, muscle imbalance leads to high arches and claw toes. Surgeons can transfer stronger tendons (for example, tibialis posterior or peroneus longus) to weaker positions to rebalance the foot and reduce deforming forces. Purpose: improve foot position, reduce ankle sprains, and help you walk with a flatter, more stable foot.medschool.cuanschutz.edu+4PMC+4PMC+4

2. Osteotomy (bone-cutting and realignment)
When deformities become structural, bones may need to be cut and repositioned. Examples include calcaneal (heel) osteotomy or first metatarsal osteotomy for a cavovarus foot. Purpose: achieve a plantigrade (flat-on-the-ground) foot and correct high arches or varus heels so that braces and shoes fit better and pain decreases.Ortho Children Center+4PMC+4PMC+4

3. Soft-tissue releases (Achilles tendon or plantar fascia)
Tight Achilles tendons and plantar fascia can lock the foot in a downward or cavus position. Surgeons may lengthen the Achilles tendon or release the plantar fascia to increase ankle and foot flexibility. Purpose: reduce toe-walking, allow the heel to touch the ground, and improve walking efficiency.www.elsevier.com+2Ortho Children Center+2

4. Arthrodesis (joint fusion)
If foot joints are stiff and arthritic, or if previous procedures fail, fusion (triple arthrodesis or hindfoot fusion) may be needed. Purpose: permanently stabilize the foot in a better alignment, reduce severe pain, and allow more effective bracing. The trade-off is loss of motion in the fused joints, so fusion is usually reserved for severe or late deformities.Radiological Society of North America+2ENMC+2

5. Hand and carpal tunnel surgery
Some people with CMT also develop carpal tunnel syndrome, where the median nerve is compressed at the wrist. Carpal tunnel release surgery cuts the ligament over the nerve to relieve pressure. Purpose: reduce numbness, tingling, and weakness in the hands, improving grip and fine-motor tasks. Studies show meaningful improvement in CMT patients who have true compressive neuropathies in addition to their inherited neuropathy.ResearchGate+4Charcot-Marie-Tooth Disease+4Hand Surgery Resource+4

---

Prevention of Complications

You cannot prevent the genetic change in PMP2, but you can reduce complications:

1. Avoid foot injuries by using well-fitting shoes, checking feet daily, and treating blisters or cuts early.medschool.cuanschutz.edu+1

2. Prevent falls with braces, balance training, home safety changes, and adequate lighting.Muscular Dystrophy Association+1

3. Keep a healthy weight to limit stress on weak joints and improve endurance.Frontiers+1

4. Stay physically active within safe limits; avoid complete inactivity that causes additional muscle loss.nhs.uk+2Charcot-Marie-Tooth Disease+2

5. Avoid smoking and excessive alcohol, which can damage nerves further and worsen balance.Frontiers+1

6. Manage other diseases like diabetes or vitamin deficiencies that can add extra neuropathy.NCBI+2Cleveland Clinic+2

7. Use protective gear (ankle braces, knee pads if needed) during sport or high-risk activities.medschool.cuanschutz.edu+1

8. Keep vaccinations up to date, especially for infections that might cause severe weakness or hospital stays.MDPI

9. Attend regular specialist check-ups so that changes are caught early and treatment can be adjusted.PMC+1

10. Seek mental health and social support to prevent burnout and depression, which can indirectly worsen physical health.Charcot-Marie-Tooth Association+1

---

When to See Doctors

You should see a doctor (ideally a neurologist with experience in CMT) regularly, even if you feel “stable.” Make an urgent appointment if you notice sudden worsening of weakness, new severe pain, rapid changes in walking, repeated falls, new hand clumsiness, or signs of another nerve problem (for example, very sudden numbness on one side). Also see your doctor promptly for non-healing foot sores, severe back pain, bladder problems, or mood changes like strong anxiety or depression. These might signal complications or a second condition that needs extra testing and treatment.MDPI+3PMC+3medschool.cuanschutz.edu+3

---

What to Eat and What to Avoid

1. Eat: plenty of colourful vegetables and fruits every day for vitamins and antioxidants. Avoid: relying on sugary drinks and sweets that add calories without nutrients.Frontiers+1

2. Eat: whole grains (brown rice, oats, whole-wheat bread) for steady energy. Avoid: mostly white flour and ultra-processed snacks that spike blood sugar and energy.Frontiers+1

3. Eat: lean protein (fish, eggs, beans, poultry) to support muscle maintenance. Avoid: very high intake of processed meats and deep-fried foods that increase inflammation.Frontiers+1

4. Eat: sources of omega-3 fats (fatty fish, flaxseed, walnuts) which may support nerve health. Avoid: trans fats and excessive saturated fat from fast food and packaged baked goods.Wiley Online Library+3PMC+3Frontiers+3

5. Eat: foods rich in B12 and other B-vitamins (meat, fish, eggs, dairy, or fortified foods if vegetarian), unless your doctor says otherwise. Avoid: long-term very restrictive diets without medical guidance.MDPI+3NCBI+3Cleveland Clinic+3

6. Eat: calcium and vitamin D-containing foods (dairy, fortified plant milks, leafy greens) for bone health. Avoid: very high soda intake, which may replace healthier drinks.MDPI

7. Eat: small, regular meals to keep energy stable and support exercise. Avoid: heavy, very late meals that disturb sleep and increase reflux.MDPI+1

8. Drink: enough water during the day. Avoid: frequent sugary drinks or excessive caffeine, which can worsen sleep and anxiety.Frontiers+1

9. Use supplements only under medical advice. Avoid megadoses of vitamins or “nerve boosters” sold online without strong evidence, as some (like high-dose B6 or untested herbal blends) can actually damage nerves or interact with drugs.MDPI+3PubMed+3NCBI+3

10. Aim for long-term, sustainable eating habits. Avoid extreme fad diets that promise fast cures for neuropathy – there is no special “CMT diet,” only general healthy patterns that support overall function.Frontiers+2Dove Medical Press+2

---

Frequently Asked Questions (FAQs)

1. Is PMP2-related Charcot-Marie-Tooth disease type 1 curable?
No. Right now, PMP2-related CMT1 has no cure and no approved gene-targeted drug. Treatment focuses on managing symptoms (pain, weakness, deformities), staying mobile, and preventing complications. Researchers are actively working on gene therapy and other regenerative treatments for CMT, but these are still experimental.PMC+3PMC+3CMT Research Foundation+3

2. Will everyone with PMP2-related CMT1 end up in a wheelchair?
Not necessarily. Many people have mild to moderate disability and keep walking with braces and therapy throughout life. Some may need a wheelchair or scooter for long distances or at older ages. Early rehabilitation, braces, and surgery when needed can greatly improve long-term mobility.medschool.cuanschutz.edu+3Charcot-Marie-Tooth Association+3CMT Research Foundation+3

3. Does starting therapy early really make a difference?
Yes. Starting physical and occupational therapy early helps maintain strength, flexibility, and balance before deformities become fixed. Early orthotics and shoe adaptations also slow progression of foot problems and reduce falls, so early intervention is strongly recommended in CMT care.nhs.uk+2Muscular Dystrophy Association+2

4. Are there special exercises I must avoid?
High-impact activities (jumping, running on hard surfaces) and heavy weightlifting that stresses weak ankles or knees can increase injury risk. Most experts recommend low-impact aerobic exercise, gentle strengthening, and good supervision by a therapist familiar with neuromuscular disorders.nhs.uk+2Charcot-Marie-Tooth Disease+2

5. Can medicines like gabapentin or duloxetine fix the nerves?
No. These drugs reduce pain and improve quality of life but do not repair the underlying genetic nerve damage. They are “symptom-control” medicines. That is why non-drug treatments, safe activity, and long-term follow-up remain essential even when pain is controlled.FDA Access Data+3FDA Access Data+3FDA Access Data+3

6. Are experimental treatments such as PXT3003 or gene therapy available for me now?
These treatments are currently being studied in clinical trials, mainly for CMT1A or other subtypes. Access is usually limited to patients who join specific research studies. For PMP2-related CMT1, you can ask your neurologist about registries or research programmes, but routine use outside trials is not available.PMC+4ClinicalTrials.gov+4ClinicalTrials.gov+4

7. Is stem cell therapy a real option right now?
At present, stem cell therapy is experimental and not recommended as standard treatment for CMT. Some clinics may advertise expensive stem cell “cures” without solid evidence. It is safest to join only ethically approved clinical trials supervised by recognised centres.PMC+2Frontiers+2

8. Can diet alone reverse my neuropathy?
No diet can reverse a PMP2 gene mutation. However, a healthy, balanced diet can support your general health, maintain a good weight, and may help your body cope better with the disease and with rehabilitation. Diet is a helpful support but not a cure.Frontiers+2Dove Medical Press+2

9. Should I take alpha-lipoic acid or other supplements on my own?
Do not start high-dose supplements on your own. Some, like alpha-lipoic acid or acetyl-L-carnitine, have mixed evidence and may help in other neuropathies, but they can interact with medicines or be harmful in some situations. Always discuss them with your doctor first.ScienceDirect+4PubMed+4PubMed+4

10. Can PMP2-related CMT1 affect my breathing or heart?
Most people with CMT1 have mainly limb problems, but in some cases other muscles can be affected. Shortness of breath, severe fatigue, or palpitations should always be checked by a doctor so that heart or lung issues are not missed.Charcot-Marie-Tooth Association+2FDA Access Data+2

11. Is it safe to become pregnant if I have PMP2-related CMT1?
Many people with CMT have successful pregnancies. However, there is a genetic risk for children, and pregnancy can temporarily worsen symptoms because of weight gain and hormonal changes. Pre-pregnancy counselling with a neurologist and genetic counsellor is recommended.MDPI+3Orpha+3PMC+3

12. Will my condition get worse quickly as I get older?
PMP2-related CMT1, like other CMT1 forms, usually progresses slowly over many years. Some people plateau for long periods. Regular monitoring, safe exercise, and early treatment of problems help keep you functioning as well as possible for as long as possible.Hand Surgery Resource+3Charcot-Marie-Tooth Association+3CMT Research Foundation+3

13. How often should I see my neurologist?
Many experts suggest at least yearly visits if you are stable, and more often if you are in a growth spurt, having new symptoms, or planning surgery or pregnancy. Your doctor may adjust this schedule based on your situation.PMC+2Frontiers+2

14. Can school or work be adapted for me?
Yes. Schools and workplaces can usually provide extra time, accessible classrooms or offices, closer parking, and flexible schedules. Occupational therapists can help identify what you need and write recommendations.Charcot-Marie-Tooth Association+1

15. What is the most important thing I can do right now?
The most important steps are: stay connected with a knowledgeable neurologist, follow a regular physiotherapy and exercise plan, use braces or orthotics if recommended, protect your feet, and look after your mental health. These actions, done consistently, often make more difference to your daily life than any single pill or supplement.MDPI+4nhs.uk+4Muscular Dystrophy Association+4

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.